$STSS
Sharps Technology Inc. Stock $stss

$stss Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000149315223017368 Filed on May 15, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue			$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.308M	$1.984M	$830.9K
YoY Change	3.46%	138.76%	85.65%
% of Gross Profit
Research & Development	$224.3K	$333.9K	$506.4K
YoY Change	-59.73%	-34.06%	8.3%
% of Gross Profit
Depreciation & Amortization	$232.6K	$212.1K	$73.05K
YoY Change	180.04%	190.36%
% of Gross Profit
Operating Expenses	$2.532M	$2.318M	$1.337M
YoY Change	-9.16%	73.32%	46.13%
Operating Profit	-$2.532M	-$2.318M	-$1.337M
YoY Change	-9.16%	73.32%
Interest Expense	$16.62K	$21.88K	-$245.4K
YoY Change	-101.51%	-108.91%	-54642.22%
% of Operating Profit
Other Income/Expense, Net	-$73.49K	$206.0K	-$287.0K
YoY Change	-102.25%	-171.77%
Pretax Income	-$2.606M	-$2.112M	-$1.870M
YoY Change	-645.44%	12.95%	104.41%
Income Tax
% Of Pretax Income
Net Earnings	-$2.606M	-$2.112M	-$1.870M
YoY Change	-645.43%	12.95%	104.41%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.22	-$0.20	-$0.36
Diluted Earnings Per Share	-$0.22	-$0.20	-$203.8K
COMMON SHARES
Basic Shares Outstanding	11.66M shares	11.66M shares	5.187M shares
Diluted Shares Outstanding	11.66M shares	10.73M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.924M	$5.257M	$255.6K
YoY Change	-62.55%	1956.67%
Cash & Equivalents	$2.924M	$5.257M	$255.6K
Short-Term Investments
Other Short-Term Assets	$193.9K	$123.4K	$7.000K
YoY Change	445.53%	1663.14%
Inventory	$992.5K	$546.7K	$122.0K
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$4.110M	$5.927M	$384.6K
YoY Change	-48.43%	1441.18%
LONG-TERM ASSETS
Property, Plant & Equipment	$7.093M	$7.244M	$3.940M
YoY Change	69.64%	83.86%
Goodwill
YoY Change
Intangibles	$60.99K	$63.42K
YoY Change
Long-Term Investments
YoY Change
Other Assets	$590.7K	$359.8K	$610.8K
YoY Change	-79.44%	-41.09%
Total Long-Term Assets	$7.684M	$7.604M	$4.551M
YoY Change	8.91%	67.09%
TOTAL ASSETS
Total Short-Term Assets	$4.110M	$5.927M	$384.6K
Total Long-Term Assets	$7.684M	$7.604M	$4.551M
Total Assets	$11.79M	$13.53M	$4.935M
YoY Change	-21.51%	174.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$825.6K	$949.2K	$852.4K
YoY Change	47.88%	11.36%
Accrued Expenses	$574.1K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$906.4K
YoY Change		-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.913M	$2.372M	$3.308M
YoY Change	-3.68%	-28.28%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.913M	$2.372M	$3.308M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$3.105M	$2.564M	$3.308M
YoY Change	2.67%	-22.48%
SHAREHOLDERS EQUITY
Retained Earnings	-$20.03M	-$17.42M
YoY Change	66.05%
Common Stock	$1.166K	$1.166K
YoY Change	26.46%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$8.689M	$10.97M	$1.627M
YoY Change
Total Liabilities & Shareholders Equity	$11.79M	$13.53M	$4.935M
YoY Change	-21.51%	174.17%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$2.606M	-$2.112M	-$1.870M
YoY Change	-645.43%	12.95%	104.41%
Depreciation, Depletion And Amortization	$232.6K	$212.1K	$73.05K
YoY Change	180.04%	190.36%
Cash From Operating Activities	-$2.068M	-$2.063M	-$1.216M
YoY Change	10.19%	69.62%	69.82%
INVESTING ACTIVITIES
Capital Expenditures	$179.3K	$163.3K
YoY Change	-138.69%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	-$40.00K
YoY Change	-100.0%	-100.0%	-46.67%
Cash From Investing Activities	-$179.3K	-$163.3K	-$40.00K
YoY Change	-93.54%	308.18%	-95.68%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	$3.239M	32.50K
YoY Change	-100.0%	9865.26%	-97.52%
NET CHANGE
Cash From Operating Activities	-2.068M	-$2.063M	-1.216M
Cash From Investing Activities	-179.3K	-$163.3K	-40.00K
Cash From Financing Activities	0.000	$3.239M	32.50K
Net Change In Cash	-2.248M	$1.086M	-1.224M
YoY Change	-129.76%	-188.79%	269.57%
FREE CASH FLOW
Cash From Operating Activities	-$2.068M	-$2.063M	-$1.216M
Capital Expenditures	$179.3K	$163.3K
Free Cash Flow	-$2.248M	-$2.226M	-$1.216M
YoY Change	58.99%	83.05%	-1007.97%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001737995
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	STSS	Subsequent Events SubsequentEvents		usd
CY2022Q4	STSS	Subsequent Events SubsequentEvents		usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent		usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
CY2023Q1	STSS	Fair Market Value Adjustment For Contingent Warrants FairMarketValueAdjustmentForContingentWarrants		usd
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax		usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets		usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2023Q1	STSS	Payments To Acquire Other Assets Escrow PaymentsToAcquireOtherAssetsEscrow		usd
CY2022Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
CY2023Q1	STSS	Proceeds From Subscriptions Receivable ProceedsFromSubscriptionsReceivable		usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations		usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023Q1	STSS	Common Stock Issued And Vested Stock Options For Fixed Assets Acquired CommonStockIssuedAndVestedStockOptionsForFixedAssetsAcquired		usd
CY2023Q1	STSS	Common Stock Issued And Vested Stock Options Issued As Consideration For Acquisition CommonStockIssuedAndVestedStockOptionsIssuedAsConsiderationForAcquisition		usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-41355
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	Sharps Technology, Inc.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	82-3751728
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	105 Maxess Road
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Melville
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	11747
CY2023Q1	dei	City Area Code CityAreaCode	(631)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	574 -4436
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	11655936	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5257246	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4170897	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	123422	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	66749	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	546720	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	185804	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	5927388	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	4423450	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7243907	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7004890	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	359791	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	411316	usd
CY2023Q1	us-gaap	Assets Assets	13531086	usd
CY2022Q4	us-gaap	Assets Assets	11839656	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	949235	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	854684	usd
CY2023Q1	STSS	Warrant Liability WarrantLiability	1423079	usd
CY2022Q4	STSS	Warrant Liability WarrantLiability	1151838	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	2372314	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2006522	usd
CY2023Q1	STSS	Deferred Tax Liability DeferredTaxLiability	192000	usd
CY2022Q4	STSS	Deferred Tax Liability DeferredTaxLiability	192000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	2564314	usd
CY2022Q4	us-gaap	Liabilities Liabilities	2198522	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	1	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	1	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	1	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	1	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	11655936	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	11655936	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9407415	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9407415	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	1166	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	941	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	27899566	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	24733306	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	485236	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	214253	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-17419196	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-15307366	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	10966772	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	9641134	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13531086	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11839656	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	333888	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	506375	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1983912	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	830909	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	2317800	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	1337284	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2317800	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1337284	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	36792	usd
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-245437	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	184085	usd
CY2022Q1	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	-287000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-14907	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	205970	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-532437	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2111830	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1869721	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.20
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.36
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10731544	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5187082	shares
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2111830	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1869721	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	270983	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1840847	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1869721	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3136197	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1869721	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	328460	usd
CY2022Q1	STSS	Stock Issued During Period Collections Of Common Stock Subscriptions Value StockIssuedDuringPeriodCollectionsOfCommonStockSubscriptionsValue	32500	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	1627436	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	9641134	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	9641134	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2111830	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2783385	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	383100	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	270983	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	10966772	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	10966772	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2111830	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1869721	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	216090	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	73050	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	383100	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	233947	usd
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	206417	usd
CY2022Q1	STSS	Fair Market Value Adjustment For Contingent Warrants FairMarketValueAdjustmentForContingentWarrants	287000	usd
CY2023Q1	STSS	Fair Market Value Adjustment For Contingent Warrants And Warrants FairMarketValueAdjustmentForContingentWarrantsAndWarrants	-184085	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	6681	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	56674	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-1000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	360916	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	36227	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	94553	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-137744	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2062670	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1216051	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	163272	usd
CY2022Q1	STSS	Payments To Acquire Other Assets Escrow PaymentsToAcquireOtherAssetsEscrow	40000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-163272	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-40000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	3238711	usd
CY2022Q1	STSS	Proceeds From Subscriptions Receivable ProceedsFromSubscriptionsReceivable	32500	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3238711	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	32500	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	73580	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1086349	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1223551	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4170897	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1479166	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5257246	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	255615	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	39111	usd
CY2022Q1	STSS	Common Stock Issued And Vested Stock Options For Fixed Assets Acquired CommonStockIssuedAndVestedStockOptionsForFixedAssetsAcquired	63612	usd
CY2022Q1	STSS	Common Stock Issued And Vested Stock Options Issued As Consideration For Acquisition CommonStockIssuedAndVestedStockOptionsIssuedAsConsiderationForAcquisition	40901	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84E_eus-gaap--UseOfEstimates_za0lxrrUISm9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_zF1HXRctIKUf">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. As of March 31, 2023, the most significant estimates relate to derivative liabilities and stock-based compensation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2023Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	167110	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	106088	usd
CY2023Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	131848	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	49144	usd
CY2023Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	247762	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	30572	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	546720	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	185804	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8135740	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7684614	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	891833	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	679724	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7243907	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7004890	usd
CY2023Q1	us-gaap	Depreciation Depreciation	212109	usd
CY2022Q1	us-gaap	Depreciation Depreciation	73050	usd
CY2023Q1	STSS	Remaining Payments Due On Machinery RemainingPaymentsDueOnMachinery	100000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	63424	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	62480	usd
CY2023Q1	us-gaap	Deposits Assets DepositsAssets	283997	usd
CY2022Q4	us-gaap	Deposits Assets DepositsAssets	336466	usd
CY2023Q1	STSS	Other Non Current OtherNonCurrent	12370	usd
CY2022Q4	STSS	Other Non Current OtherNonCurrent	12370	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	359791	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	411316	usd
CY2023Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	3980	usd
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000	shares
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2019Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000	shares
CY2019Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Conversion Of Stock Description ConversionOfStockDescription	Pursuant to the merger agreement, (i) the Company merged with and into Sharps Nevada, (ii) each 3.5 shares of common stock of the Company were converted into one share of common stock of Sharps Nevada and (iii) the articles of incorporation and bylaws of Sharps Nevada, became the articles of incorporation and bylaws of the surviving corporation.
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2800000	usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	455326	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	9000000.0	usd
CY2022Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	5200000	usd
	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	235000	shares
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	290551	usd
CY2023Q1	STSS	Warrant Liability WarrantLiability	1423079	usd
CY2023Q1	STSS	Warrant Liability WarrantLiability	1423079	usd
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	11296316	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	11296316	shares
CY2023Q1	STSS	Fair Market Value Of Note Warrants FairMarketValueOfNoteWarrants	30588	usd
CY2023Q1	STSS	Fair Market Value Of Trading And Overall Warrants FairMarketValueOfTradingAndOverallWarrants	1121250	usd
CY2023Q1	STSS	Fair Market Value Of Trading And Overall Warrants Issuance FairMarketValueOfTradingAndOverallWarrantsIssuance	455326	usd
CY2023Q1	STSS	Fair Market Value Of Change In Fair Value Of Warrant Liability FairMarketValueOfChangeInFairValueOfWarrantLiability	184085	usd
CY2023Q1	STSS	Warrant Liability WarrantLiability	1423079	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1358122	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.37
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1025000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.37
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2383122	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.08
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1457904	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.94
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	932443	usd
CY2023Q1	STSS	Stock Based Charges Relating To Purchase Of Machinery StockBasedChargesRelatingToPurchaseOfMachinery	63512	usd
CY2023Q1	STSS	Stock Based Charges Relating To Acquisition StockBasedChargesRelatingToAcquisition	40901	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation Disposition Of Business EffectiveIncomeTaxRateReconciliationDispositionOfBusiness	0	pure
CY2022Q1	us-gaap	Effective Income Tax Rate Reconciliation Disposition Of Business EffectiveIncomeTaxRateReconciliationDispositionOfBusiness	0	pure
CY2023Q1	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	5257246	usd
CY2023Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	5257246	usd
CY2023Q1	STSS	Warrant Liability WarrantLiability	1423079	usd
CY2023Q1	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	1423079	usd
CY2023Q1	STSS	Order Costs To Purchase Equipment And Molds OrderCostsToPurchaseEquipmentAndMolds	521257	usd
CY2023Q1	STSS	Progress Payments ProgressPayments	209678	usd
CY2023Q1	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	235000	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	50000	shares
CY2023Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	1.30

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
stss-20230331_def.xml	Edgar Link	unprocessable
0001493152-23-017368-index-headers.html	Edgar Link	pending
0001493152-23-017368-index.html	Edgar Link	pending
0001493152-23-017368.txt	Edgar Link	pending
0001493152-23-017368-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
stss-20230331.xsd	Edgar Link	pending
stss-20230331_cal.xml	Edgar Link	unprocessable
stss-20230331_lab.xml	Edgar Link	unprocessable
stss-20230331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$STSS
Sharps Technology Inc. Stock $stss

2023 Q2 Form 10-Q Financial Statement

#000149315223017368 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$STSS Sharps Technology Inc. Stock $stss

2023 Q2 Form 10-Q Financial Statement

#000149315223017368 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$STSS
Sharps Technology Inc. Stock $stss